CEDRA offers comprehensive services for bioequivalency studies. Our pharmacokinetic team is available to assist with protocol design as well as statistical analysis. Our final study reports for FDA submission are produced using Liquent InSight Publisher™, which automatically compiles source documents with varying file formats into one seamless publication. This technology also supports reporting from Watson™ LIMS and other software programs.

Bioequivalency Services include: